中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
33期
5395-5401
,共7页
宗强%李立军%姜竹岩%时宇博%倪东馗
宗彊%李立軍%薑竹巖%時宇博%倪東馗
종강%리립군%강죽암%시우박%예동규
组织构建%骨组织工程%骨密度%Ⅰ型胶原α1%Sp1%多态性%骨折%Meta分析
組織構建%骨組織工程%骨密度%Ⅰ型膠原α1%Sp1%多態性%骨摺%Meta分析
조직구건%골조직공정%골밀도%Ⅰ형효원α1%Sp1%다태성%골절%Meta분석
Fractures,Bone%Collagen Type I%Bone Density%Meta-Analysis
背景:到目前为止,多项研究已经对Sp1多态性对骨质疏松和骨折的风险做出了评估。有报道称这种多态性与骨密度降低和骨折有密切联系,但也有研究称未发现类似联系,这些结果导致了很大的争议。目的:通过仅纳入病例对照研究的Meta分析来评价Ⅰ型胶原α1 Sp1多态性对骨密度和骨折的影响。方法:检索MEDLINE,EMBASE,PubMed数据库有关Ⅰ型胶原α1 Sp1对骨密度和骨折影响的病例对照研究,计算合并效应值比值比(ORs)及其95%可信区间(95%CI)。并对异质性和偏倚进行评估。结果与结论:共32篇文献符合纳入标准。其中有22项研究评价了Sp1多态性对骨折的影响,在5个基因模型中均可发现 Sp1多态性与骨折危险性有关联,但在亚组分析中,仅在欧洲人群有类似结果。有13项研究评价了Sp1多态性对骨密度降低的影响,结果发现Sp1与骨密度降低有密切关系,亚组分析在欧洲和美洲人群中有类似结果,但是在亚洲人群中并无类似发现。总体来说,Ⅰ型胶原α1 Sp1多态性是骨折和骨密度降低的危险因素,但也存在地区即地理性差异性。
揹景:到目前為止,多項研究已經對Sp1多態性對骨質疏鬆和骨摺的風險做齣瞭評估。有報道稱這種多態性與骨密度降低和骨摺有密切聯繫,但也有研究稱未髮現類似聯繫,這些結果導緻瞭很大的爭議。目的:通過僅納入病例對照研究的Meta分析來評價Ⅰ型膠原α1 Sp1多態性對骨密度和骨摺的影響。方法:檢索MEDLINE,EMBASE,PubMed數據庫有關Ⅰ型膠原α1 Sp1對骨密度和骨摺影響的病例對照研究,計算閤併效應值比值比(ORs)及其95%可信區間(95%CI)。併對異質性和偏倚進行評估。結果與結論:共32篇文獻符閤納入標準。其中有22項研究評價瞭Sp1多態性對骨摺的影響,在5箇基因模型中均可髮現 Sp1多態性與骨摺危險性有關聯,但在亞組分析中,僅在歐洲人群有類似結果。有13項研究評價瞭Sp1多態性對骨密度降低的影響,結果髮現Sp1與骨密度降低有密切關繫,亞組分析在歐洲和美洲人群中有類似結果,但是在亞洲人群中併無類似髮現。總體來說,Ⅰ型膠原α1 Sp1多態性是骨摺和骨密度降低的危險因素,但也存在地區即地理性差異性。
배경:도목전위지,다항연구이경대Sp1다태성대골질소송화골절적풍험주출료평고。유보도칭저충다태성여골밀도강저화골절유밀절련계,단야유연구칭미발현유사련계,저사결과도치료흔대적쟁의。목적:통과부납입병례대조연구적Meta분석래평개Ⅰ형효원α1 Sp1다태성대골밀도화골절적영향。방법:검색MEDLINE,EMBASE,PubMed수거고유관Ⅰ형효원α1 Sp1대골밀도화골절영향적병례대조연구,계산합병효응치비치비(ORs)급기95%가신구간(95%CI)。병대이질성화편의진행평고。결과여결론:공32편문헌부합납입표준。기중유22항연구평개료Sp1다태성대골절적영향,재5개기인모형중균가발현 Sp1다태성여골절위험성유관련,단재아조분석중,부재구주인군유유사결과。유13항연구평개료Sp1다태성대골밀도강저적영향,결과발현Sp1여골밀도강저유밀절관계,아조분석재구주화미주인군중유유사결과,단시재아주인군중병무유사발현。총체래설,Ⅰ형효원α1 Sp1다태성시골절화골밀도강저적위험인소,단야존재지구즉지이성차이성。
BACKGROUND:Currently, there are large numbers of studies related to the association between colagen type I alpha1 (COL1A1) Sp1 polymorphism and bone mineral density and fracture risk, but the results are inconsistent. OBJECTIVE:To evaluate the impact of the COL1A1 Sp1 polymorphism on bone mineral density and fracture by using the Meta-analysis. METHODS:We comprehensively searched the eligible studies for the present meta-analysis through MEDLINE, PubMed, EMBASE databases. Pooled odds ratios and 95% confidence intervals of Sp1 polymorphisms for bone mineral density and fracture risk were obtained, with attention to study quality and publication bias. RESULTS AND CONCLUSION:A total of 32 studies met the inclusion criteria, among which, 22 studies evaluated the Sp1 polymorphism and fracture risk. Significant associations were found in five genetic models. In the stratified analysis by region, the same results were found in the Europeans but not Americans and Asians. Thirteen studies evaluated the Sp1 polymorphism and low bone mineral density risk. A similar result was obtained. However, the analysis of bone mineral density data showed an increased relation between Sp1 polymorphism and low bone mineral density in Europeans and Americans but not in Asians. Overal, the current meta-analysis concludes that the COL1A1 Sp1 polymorphism is associated with low bone mineral density and fracture risk, especialy in Europeans. However, susceptibility to them varies markedly among populations from different regions.